TITLE

Minocycline: Therapeutic Potential in Psychiatry

AUTHOR(S)
Dean, Olivia M.; Data-Franco, João; Giorlando, Francesco; Berk, Michael
PUB. DATE
May 2012
SOURCE
CNS Drugs;2012, Vol. 26 Issue 5, p391
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Pharmacological interventions to treat psychiatric illness have previously focused on modifying dysfunctional neurotransmitter systems to improve symptoms. However, imperfect understanding of the aetiology of these het-erogeneous syndromes has been associated with poor treatment outcomes for many individuals. Growing evidence suggests that oxidative stress, inflamma-tion, changes in glutamatergic pathways and neurotrophins play important roles in many psychiatric illnesses including mood disorders, schizophrenia and addiction. These novel insights into pathophysiology allow new treat-ment targets to be explored. Minocycline is an antibiotic that can modulate glutamate-induced excitotoxicity, and has antioxidant, anti-inflammatory and neuroprotective effects. Given that these mechanisms overlap with the newly understood pathophysiological pathways, minocycline has potential as an adjunctive treatment in psychiatry. To date there have been promising clinical indications that minocycline may be a useful treatment in psychiatry, albeit from small trials most of which were not placebo controlled. Case reports of individuals with schizophrenia, psychotic symptoms and bipolar depression have shown serendipitous benefits of minocycline treatment on psychiatric symptoms. Minocycline has been trialled in open-label or small ran-domized controlled trials in psychiatry. Results vary, with findings supporting use in schizophrenia, but showing less benefit for nicotine dependence and obsessive-compulsive disorder. Given the limited data from rigorous clinical trials, further research is required. However, taken together, the current evidence suggests minocycline may be a promising novel therapy in psychiatry.
ACCESSION #
76477730

 

Related Articles

  • Assessment of oxidative stress in adolescents with acne vulgaris and anxiety disorders. Demirkaya, Sevcan Karakoç; Pektas, Suzan Demir; Küçükköse, Mustafa; Ertugrul, Özden; Erel, Özcan // Biomedical Research (0970-938X);2016, Vol. 27 Issue 3, p888 

    Objectives: Anxiety disorders (AD) are common comorbid conditions with acne vulgaris (AV). Oxidative mechanisms play roles in the pathogenesis of both AV and AD. We aimed to evaluate the oxidative-antioxidative status in patients diagnosed with AD and AV. Methods: A total of 126 adolescents...

  • Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. Sacktor, Ned; Miyahara, Sachiko; Evans, Scott; Schifitto, Giovanni; Cohen, Bruce; Haughey, Norman; Drewes, Julia; Graham, David; Zink, M.Christine; Anderson, Caroline; Nath, Avindra; Pardo, Carlos; McCarthy, Sean; Hosey, Lara; Clifford, David // Journal of NeuroVirology;Dec2014, Vol. 20 Issue 6, p620 

    Elevated cerebrospinal fluid (CSF) levels of markers of oxidative stress, neuronal injury, and inflammation and decreased neurotransmitter levels have been reported in HIV-associated neurocognitive disorders (HAND). Minocycline may have a neuroprotective effect by inhibiting inducible nitric...

  • The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Moylan, S; Maes, M; Wray, N R; Berk, M // Molecular Psychiatry;May2013, Vol. 18 Issue 5, p595 

    In some patients with major depressive disorder (MDD), individual illness characteristics appear consistent with those of a neuroprogressive illness. Features of neuroprogression include poorer symptomatic, treatment and functional outcomes in patients with earlier disease onset and increased...

  • Nongenetic factors play role in causing schizophrenia. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;02/25/98, Vol. 11 Issue 2, p22 

    Reveals the nongenetic causes of schizophrenia in persons who are genetically vulnerable to the illness. Stochastic developmental elements; Utero difficulties; Perinatal complications.

  • Oxidative stress in schizophrenia: a case--control study on the effects on social cognition and neurocognition. Gonzalez-Liencres, Cristina; Tas, Cumhur; Brown, Elliot C.; Erdin, Soner; Onur, Ece; Cubukcoglu, Zeynep; Aydemir, Omer; Esen-Danaci, Aysen; Brüne, Martin // BMC Psychiatry;2014, Vol. 14 Issue 1, p1 

    Background Schizophrenia is a debilitating mental disorder that presents impairments in neurocognition and social cognition. Several studies have suggested that the etiology of schizophrenia can be partly explained by oxidative stress. However, our knowledge about the implications of oxidative...

  • Use of Anterior Tibia! Translation in the Management of Patellofemoral Pain Syndrome in Older Patients: A Case Series. Creighton, Doug; Krauss, John; Kondratek, Melodie; Huijbregts, Peter A.; Will, Andrea // Journal of Manual & Manipulative Therapy (Journal of Manual & Ma;2007, Vol. 15 Issue 4, p216 

    The currently most plausible pathophysiologic theory for the etiology of pain in patients with patellofemoral pain syndrome involves abnormal mechanical stress to the patellofemoral joint. At this time, there is no consensus nor is there a sufficient body of research evidence to guide management...

  • Comparative study on the incidence and outcomes of pigmented versus non pigmented keratomycosis. Sengupta, Sabyasachi; Rajan, Sanjeevani; Reddy, Padmati Ravindranath; Thiruvengadakrishnan, Krishnan; Ravindran, Ravilla D.; Lalitha, Prajna; Manivasagam Vaitilingam, C. // Indian Journal of Ophthalmology;Jul2011, Vol. 59 Issue 4, p291 

    To determine the incidence, outcomes and establish factors determining visual prognosis of keratomycosis due to pigmented fungi in comparison with nonpigmented fungi. Materials and Methods: All culture-proven cases of fungal keratitis from January 2006 to August 2008 were drawn from a...

  • Chronic Kidney disease: risk factors, assessment and nursing care. Redmond, Avril; McClelland, Heather // Nursing Standard;11/15/2006, Vol. 21 Issue 10, p48 

    This article provides an overview of chronic kidney disease in adults and outlines nursing management in primary and secondary care. Patient assessment, including the stages of chronic kidney disease, common causes and risk factors, are also discussed.

  • Relapse in schizophrenia. Wing, J.K. // British Medical Journal (Clinical Research Edition);11/2/1985, Vol. 291 Issue 6504, p1219 

    Focuses on the mental illness called Schizophrenia. Manifestations of the disorder; Positive and negative symptoms schizophrenia; Diagnosis of the mental illness.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics